BA vs UNH: Which Is the Better Buy?

Side-by-side comparison of The Boeing Company and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-22.
The Boeing Company · Industrials
$201.15
+31.7% upside to fair value
Med Conviction Grade B
VS
UnitedHealth Group Incorporated · Healthcare
$375.21
+28.2% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
BA has more upside to fair value (+31.7%). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric BA UNH
Current Price $201.15 $375.21
Fair Value Estimate $265.00 $481.06
Upside to Fair Value +31.7% +28.2%
Market Cap $159.0B $340.7B
Forward P/E — —
EV / EBITDA 28.4x 15.0x
Price / Sales 1.7x 0.8x
Price / FCF — 14.4x
Revenue Growth YoY +8.0% +0.4%
Gross Margin 4.7% 22.5%
Operating Margin -5.4% 4.8%
Return on Equity 104.8% 14.6%
Dividend Yield 0% 2.41%
FCF Yield — 6.95%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
BA — The Boeing Company
Boeing is a global aerospace and defense manufacturer spanning commercial airliners, military aircraft, satellites, missile defense, and aftermarket services, with roughly 182,000 employees and a business that remains structurally advantaged by the duopoly economics of large commercial aircraft and the long-cycle, high-switching-cost nature of aerospace platforms. The business quality is currentl…
UNH — UnitedHealth Group Incorporated
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
Metric BA UNH
Zone Low $198.75 $360.80
Zone High $225.25 $408.90
In Buy Zone? Yes Yes
← BA Research    UNH Research →    All Research